Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Lalwani Nikhil, holds the title of PRESIDENT & CEO at ANI PHARMACEUTICALS INC.
On 2026-11-18, the insider transacted 5,400 shares.The shares were transacted at a weighted average price of $71.22 per share, resulting in a total market-relevant value of $385K.
Lalwani Nikhil (PRESIDENT & CEO) sold $385K of $ANIP
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.